CHENGDU, China, April 4, 2011 /PRNewswire-Asia-FirstCall/ —
Tianyin Pharmaceutical Co., Inc. (NYSE Amex:
TPI), a pharmaceutical company that specializes in patented
biopharmaceutical medicine, modernized traditional Chinese
medicine, branded generics and other pharmaceuticals has updated
its corporate business & development information on
OneMedDatabase, a division of OneMedPlace, a New York-based
healthcare research and business & development firm.
The profile is to serve as a portal for TPI in the development
of partnership with U.S. as well as international pharmaceutical
companies for the further growth expansion via TPI’s in-depth
coverage of pharmaceutical sales network in China and TPI’s
upcoming macrolide antibiotic API business.
The updated profile of TPI along with an interview with the
management can be found via the following link: http://www.onemedplace.com/database/list/cid/14315
OneMedPlace (OMP), based in New York, is a healthcare research
company that manages a business development platform to help
emerging healthcare and life sciences companies maximize their
potentials. OMP provides companies and investors with efficient
access to information about potential opportunities around the
world through an integrated set of tools including:
Over 8,000 companies and resources.
biannual business development and investment conferences in San
Francisco (January) and New York City (June).
Documentaries on promising companies and technologies and important